Obesity is one of the most significant risk factors for hypertension, coronary heart disease, and NIDDM (Frayn KN Received for publication 4 December 1995 and accepted in revised form 13 February 1996.
circulating factor that can regulate fat mass by modulation of appetite and metabolism (5) , and expression studies have demonstrated a primary site of expression is adipocytes, supporting a direct role in fat metabolism (6, 10) . More recently, several groups have shown that injection of recombinant ob protein can reduce adipose mass in ob/ob and wild-type mice, suggesting that the gene plays a central role in regulating body weight in mice (7) (8) (9) . Although human obesity is a complex multifactorial disease and preliminary studies in small samples of morbidly obese subjects (11) have not identified mutations in the OB gene, the possibility remains that sequence variation in the OB gene is a cause of extreme obesity in human populations. The present study was conducted to evaluate the role of the OB gene region in genetic predisposition to morbid obesity.
RESEARCH DESIGN AND METHODS

Patients and families.
A total of 101 families were ascertained through the Department of Nutrition, Hotel-Dieu Hospital in Paris (45%) or through a multimedia recruitment campaign in France (55%). Probands were ascertained on the basis of BMI >40 kg/m 2 . Families were included in the study if probands had at least one sibling with a BMI ^27 kg/m 2 . Additional family members were ascertained and genotyped where possible. Both parents were available for genotyping in 23% of the families, and one parent was available in 34% of the families. In 25% of the families, both parents had BMIs >27 kg/m 2 , and in 41% of the families, one parent met the initial affection criteria. Radiation hybrid mapping. A panel of 83 radiation hybrid DNAs was prepared at the Stanford Genome Center and distributed through Research Genetics (12) . Presence or absence of each marker in the panel was determined by polymerase chain reaction (PCR) followed by agarose gel electrophoresis, with each marker being scored individually in two of three independent reactions. PCR reactions were carried out with the following primers and annealing conditions for each marker. Statistical analysis of marker retention patterns was conducted using RHMAXLIK (13) TET (Applied Biosystems, Foster City, CA), to enable detection. PCR was carried out in a final reaction volume of twenty microliters. Amplification occurred during 35 cycles each for 30 s at 94°C, 30 s at the primer-specific annealing temperature, followed by 30 s at 72°C. PCR products were subjected to electrophoresis on an ABI373a, using a 12-cM well-to-read denaturing 6% polyacrylamide gel, with analysis using Applied Biosystems' GeneScan 1.2. Data Analysis. Degree of allele sharing identical by descent (IBD) among affected and discordant siblings respectively was evaluated for assessment of linkage. For sib-pairs with fully informative parents, the number of alleles shared IBD was unambiguously defined. For sib-pairs with uninformative or missing parents, the method of Haseman and Elston (14) was used to estimate the proportion of alleles shared IBD. This method requires knowledge of marker allele frequencies. The present results appear to support the frequency estimates, because no appreciable differences in outcomes were observed using data from unaffected parents, the full French sample, or published Centre d'Etude du Polymorphisme Humain frequencies for the eight markers. In affected sib-pairs, the proportion of alleles shared IBD was tested against the null hypothesis of no linkage (0.50), with significant excess sharing taken as evidence for linkage. In discordant pairs, evidence for linkage was taken if a significant decrease in allele-sharing was observed. The tests of linkage were performed using the SIBPAL program in the SAGE package (15) . Haplotypes of markers D7S680 and D7S514 were constructed using the SIMWALK program (16) . Maximum logarithm of odds (LOD) score (MLS) values were derived from the haplotype sharing as described previously (17) . Tests of linkage disequilibrium were conducted using the transmission/disequilibrium test (18) .
RESULTS
Human chromosome region 7q31 contains a region of synteny with the ob locus on mouse chromosome 6 (19) . The precise location of the OB gene within this region of synteny was determined by radiation hybrid mapping (12) . Two-point linkage analysis colocalized OB and microsatellite marker D7S504 with a LOD score of 1,000. Multipoint analysis of three other markers in the region, D7S635, D7S514, and D7S680, yielded a most likely order of D7S680-D7S514-D7S635-O5. Physical distances between the markers, calculated from the distances expressed in cR8000, were estimated to be 850 kb between D7S680 and D7S514/D7S635 and 570 kb between D7S514/D7S635 and OB (D7S514 and D7S635 were not separable by this analysis). Thus, these markers scored encompass a region of ~ 1.5 Mb. The relative order and spacing of these loci by radiation hybrid mapping is consistent with the published physical map of the region (10) .
Eight microsatellite markers flanking the OB gene were genotyped in 101 French families selected for morbid obesity (Fig. 1) . Two different thresholds for obesity were evaluated for linkage analyses of the OB region: BMI >30 kg/m 2 and BMI >35 kg/m 2 . The former threshold is representative of commonly used clinical definitions of the presence of obesity (20) , while the latter threshold was chosen to reflect more severe obesity, which characterizes the ob mouse model. A more extreme threshold of obesity could not be imposed because the resulting sample size was too small for meaningful analyses. Individuals with BMI ^27 kg/m 2 were considered to be unaffected. Individuals with BMI >27 kg/m 2 and <30 or 35 kg/m 2 were assigned unknown affection status. Haplotypes of alleles at the loci D7S680 and D7S514 were constructed to create more informative markers. Results of linkage analyses of these haplotypes are presented in Table  2 . As in the assessments of the individual markers, no significant evidence for linkage was obtained for BMI >30 kg/m 2 , but significant evidence was observed using the more extreme phenotypic threshold (MLS = 2.16, P ** 0.005). An ad hoc test to assess whether the linkage results were an artifact of the rather arbitrary phenotype threshold imposed for extreme obesity (BMI >35 kg/m 2 ) was also performed. In particular, linkage results of an intermediate phenotype, using a threshold of BMI >32.5 kg/m 2 , also demonstrated linkage, although the effect was less pronounced (MLS = 1.11, P < 0.05) than with BMI >35 kg/m 2 . This outcome suggests that the threshold imposed is reasonable. It also provides further evidence suggesting that the effect of the obesity susceptibility gene in this region has a greater impact on extreme obesity than on less severe forms. Tests of linkage disequilibrium between the D7S680/D7S514 haplotype and morbid obesity did not reveal significant evidence for any BMI threshold (data not shown).
DISCUSSION
In summary, results from linkage analysis of 101 families with extreme obesity indicate that the human OB gene region may be involved in susceptibility to extreme obesity. The linked markers lie within 2 cM of the location of the human OB gene.. The flanking unlinked markers are D7S677 (7 cM proximal to the centromere) and D7S640 (7 cM (21) have suggested using a significance level of P < 0.00074 for suggestive evidence of linkage in a typical genome scan experiment in which multiple tests for linkage are carried out. However, in the present study, a specific hypothesis was tested with two markers that were first shown to map to the OB locus (D7S514 and D7S680). One of the most conservative corrections for multiple comparisons would involve, in this case, a priori selection of a significance threshold of 0.05/A/ = 0.0125 (Bonferroni) (22) where N represents the number of markers tested in that specific hypothesis (two) plus the number of diagnostic categories tested for linkage (two). Markers D7S514 and D7S680 (both P < 0.01) exceed this corrected threshold (observation <5% by chance), with nonsignificant flanking markers providing a negative control. Additionally, these results are comparable to those obtained in an independent set of families with an obesity threshold of BMI >40 kg/m 2 (22a). Our threshold for affected status (BMI >35 kg/m 2 ) was lower and was imposed because of the lack of significant numbers of affected pairs at thresholds of BMI >40 kg/m 2 in our sample (European populations rarely reach such extreme BMI values as in the U.S.). Nevertheless, the BMI cutoffs used reflect similar population extremes in both countries, with ~1.3% of the U.S. population having BMI >40 kg/m 2 and ~ 1-1.5% of the French population having BMI >35 kg/m 2 (23, 24) . This situation parallels recently reported schizophrenia studies in which replication was found using related, but not identical, affected-status classification (25) (26) (27) .
While no mutations have yet been reported in the OB gene, several studies have shown that OB mRNA levels are frequently elevated in the fat cells of obese subjects (28, 29) and that BMI is correlated with plasma leptin levels over a wide range (30) . It is unclear from these studies whether leptin is simply a marker of the obese state or whether there is a primary defect in some component of this signaling pathway (leptin levels are raised because of resistance/insensitivity). This study provides more direct evidence that sequence variation of the OB gene is likely to be a cause of some extreme obesity. Nevertheless, given the absence of significant linkage at BMI thresholds of 30 kg/m 2 , it is possible that this locus may only be important for extreme human obesity and may not play a major role in the common variation of body weight (the 2nd to 9th percentile range is approximately BMI 20-30 kg/m 2 ). Given the small number of affected individuals who are likely to carry functionally significant mutations at the OB locus and the problems associated with unambiguously identifying protective and susceptible haplotypes in complex traits, it may prove difficult to extend these linkage findings to mutation studies. Such studies may have clinical relevance, since the subset of individuals who are predisposed to extreme obesity as a result of OB mutations (rather than mutations upstream in the signaling pathway) may be the most likely to respond to therapeutic administration of the OB protein.
Extreme obesity has a significant geneticcomponent (30a), and this study demonstrates that genes predisposing to extreme obesity may be detected with the family-structure and affected-sib-pair analyses described. Genome searches in other complex traits have been successful in identifying multiple predisposing loci (31) , and it is likely that other genes in addition to OB will contribute significant components of the genetic risk to extreme obesity and that they can be identified using this approach. The characterization of other loci (particularly genes with major effects rather than the minor susceptibility effect attributable to the OB gene region) and the pathways in which they act will be important in developing rational therapies for obesity.
